THIS END UP DEPAKOTE SPRINKLE 125 mg (Depakote Sprinkles 125 mg)
Generic Name: divalproex sodium
Pill with imprint THIS END UP DEPAKOTE SPRINKLE 125 mg is Blue & White, Capsule-shape and has been identified as Depakote Sprinkles 125 mg. It is supplied by Abbott Laboratories.
Depakote Sprinkles is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Depakote Sprinkles 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for THIS END UP DEPAKOTE SPRINKLE 125 mg



Depakote Sprinkles
- Generic Name
- divalproex sodium
- Imprint
- THIS END UP DEPAKOTE SPRINKLE 125 mg
- Strength
- 125 mg
- Color
- Blue & White
- Size
- 17.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Abbott Laboratories
- Inactive Ingredients
-
silicon dioxide,
triethyl citrate,
magnesium stearate,
D&C Red No. 28,
FD&C Blue No. 1,
ferric oxide red,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00074-6114 | Abbott Laboratories |
00781-2243 | Sandoz Inc. |
55289-0991 | PDRX Pharmaceuticals Inc. (repackager) |
49999-0942 | Lake Erie Medical and Surgical Supply (repackager) |
Related Images for "THIS END UP DEPAKOTE SPRINKLE 125 mg"
More about Depakote Sprinkles (divalproex sodium)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: fatty acid derivative anticonvulsants
- FDA Alerts (5)
Consumer resources
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.